Effect of anakinra versus usual care in adults in hospital with COVID-19 and mild-to-moderate pneumonia (CORIMUNO-ANA-1): a randomised controlled trial
Pierre‐Louis Tharaux(Inserm), Robin Charreteur(Collaborative Group (United States)), Stéphanie Alary(Collaborative Group (United States)), Samir Hamiria(Collaborative Group (United States)), Matthieu Resche‐Rigon(Inserm), Thinhinane Bariz(Collaborative Group (United States)), Corine Nyanou(Collaborative Group (United States)), Mohamed Belloul(Collaborative Group (United States)), Gabriel Baron(Délégation Paris 5), Annick Tibi(Assistance Publique – Hôpitaux de Paris), Lucie Biard(Collaborative Group (United States)), Sarah Dalibey(Collaborative Group (United States)), Joseph Emmerich(Délégation Paris 5), Matthieu Mahévas(Délégation Paris 5), Moustafa Benafla(Collaborative Group (United States)), Souad Benarab(Collaborative Group (United States)), Arthur Pavot, Dhiaa Meriem Hai(Collaborative Group (United States)), Cécile Kedzia(Collaborative Group (United States)), Nabil Raked(Collaborative Group (United States)), Frédéric Pène(Centre National de la Recherche Scientifique), Hala Semri(Collaborative Group (United States)), Philippe Ravaud(Inserm), Xavier Mariette(Inserm), Lakhdar Mameri(Collaborative Group (United States)), Anouk Walter‐Petrich(Inserm), E. Ya. Stan(Collaborative Group (United States)), Yazdan Yazdanpanah(Inserm), Damien Vanhoye(Collaborative Group (United States)), Olivier Hermine(Centre National de la Recherche Scientifique), Lauren Demerville(Hôpital Saint-Louis), Raphaël Porcher(Hotel Dieu Hospital), F. Schlemmer(Collaborative Group (United States)), Karine Lacombe(Inserm), Saskia Flamand(Collaborative Group (United States)), Serge Bureau(Collaborative Group (United States)), Élie Azoulay(Hôpital Saint-Louis), Élodie Perrodeau(Collaborative Group (United States)), Anne Gysembergh-Houal(Collaborative Group (United States)), Marc Humbert(Inserm), Alexandre Bourgoin(Collaborative Group (United States)), Pernelle Vauboin(Collaborative Group (United States)), Maxime Dougados(Inserm), Gilles Pialoux, Bertrand Guidet(Sorbonne Université), Claire Montlahuc(Collaborative Group (United States)), Claire Pacheco(Collaborative Group (United States)), Valérie Pourchet-Martinez(Collaborative Group (United States)), Jacques Cadranel(Sorbonne Université), Muriel Fartoukh(Université Paris-Est Créteil)
Cited by 297
Related Papers
2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension
|European Heart Journal|2022|3.6k
Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients
|Science|2020|3.2k
Revision and Update of the Consensus Definitions of Invasive Fungal Disease From the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium
|Clinical Infectious Diseases|2019|2.8k
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update
|Annals of the Rheumatic Diseases|2020|2.8k